VIRAL PEPTIDES THAT INTERACT WITH HLA-A2 INHIBIT CYTO-TOXIC T-CELL ACTIVITY

VIRAL PEPTIDES THAT INTERACT WITH HLA-A2 INHIBIT CYTO-TOXIC T-CELL ACTIVITY

Dades bibliogràfiques
Autors principals:	Robbins, P, Mcmichael, A
Format:	Journal article
Publicat:	1988

Ítems similars

Identification of T cell receptor recognition residues for a viral peptide presented by HLA B27.
per: Bowness, P, et al.
Publicat: (1994)

Anti-viral cytotoxic T cells inhibit the growth of cancer cells with antibody targeted HLA class I/peptide complexes in SCID mice.
per: Savage, P, et al.
Publicat: (2002)

CYTO-TOXIC CHEMOTHERAPY IN BREAST-CANCER
per: Peto, R
Publicat: (1985)

24TH FORUM IN IMMUNOLOGY - HIV-SPECIFIC CYTO-TOXIC LYMPHOCYTES-T - DISCUSSION
per: Koup, R, et al.
Publicat: (1989)

HLA-peptide tetrameric complexes.
per: Ogg, G, et al.
Publicat: (1998)

Comparison between two peptide epitopes presented to cytotoxic T lymphocytes by HLA-A2. Evidence for discrete locations within HLA-A2.
per: Robbins, P, et al.
Publicat: (1989)

CYTO-TOXIC CHEMOTHERAPY IN BREAST-CANCER - REPLY
per: Peto, R
Publicat: (1985)

Anti-HLA-A2 antibody-enhancement of peptide association with HLA-A2 as detected by cytotoxic T lymphocytes.
per: Bodmer, H, et al.
Publicat: (1989)

Induction of viral and tumour specific CTL responses using antibody targeted HLA class I peptide complexes.
per: Savage, P, et al.
Publicat: (2002)

Structural homologies between two HLA B27-restricted peptides suggest residues important for interaction with HLA B27.
per: Huet, S, et al.
Publicat: (1990)

CHARACTERIZATION OF BLAST CELLS BY ULTRASTRUCTURAL CYTO-CHEMISTRY AND MONOCLONAL-ANTIBODIES
per: Miguel, J, et al.
Publicat: (1983)

Crystal structures and KIR3DL1 recognition of three immunodominant viral peptides complexed to HLA-B*2705.
per: Stewart-Jones, G, et al.
Publicat: (2005)

A cluster of mutations in HLA-A2 alpha 2 helix abolishes peptide recognition by T cells.
per: Moots, R, et al.
Publicat: (1991)

Immune recognition of HLA molecules downmodulates CD8 expression on cytotoxic T lymphocytes.
per: Robbins, P, et al.
Publicat: (1991)

Dendrimers functionalized with membrane-interacting peptides for viral inhibition
per: Tarallo R, et al.
Publicat: (2013-02-01)

IDENTIFICATION OF T-CELL RECEPTOR RECOGNITION RESIDUES FOR AN INFLUENZA-VIRUS NONAMER PEPTIDE EPITOPE PRESENTED BY HLA B27
per: Bowness, P, et al.
Publicat: (1995)

HLA-B27-RESTRICTED PEPTIDE PRESENTATION TO CYTOTOXIC T-CELLS IN REACTIVE ARTHRITIS
per: Bowness, P, et al.
Publicat: (1995)

Interaction of HLA-B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA-B27 heterotrimers, is independent of the sequence of bound peptide.
per: Kollnberger, S, et al.
Publicat: (2007)

INTERACTION BETWEEN INFLUENZA-VIRUS AND HLA ANTIGENS
per: Hildreth, J, et al.
Publicat: (1981)

Mutants of HLA-A2 in the analysis of its structure and function.
per: Strominger, J, et al.
Publicat: (1989)

HLA-KIR Interactions and Immunity to Viral Infections
per: Masoud Sabouri Ghannad, et al.
Publicat: (2014-02-01)

HLA restriction of human cytotoxic T cells.
per: Mcmichael, A
Publicat: (1980)

HLA-A2 subtypes are functionally distinct in peptide binding and presentation.
per: Barouch, D, et al.
Publicat: (1995)

Evidence of widespread binding of HLA class I molecules to peptides.
per: Frelinger, J, et al.
Publicat: (1990)

Significance of the six peptide-binding pockets of HLA-A2.1 in influenza A matrix peptide-specific cytotoxic T-lymphocyte reactivity.
per: Matsui, M, et al.
Publicat: (1994)

Cyto-Neurology in Ischemia
per: Cláudio Roque, et al.
Publicat: (2022-07-01)

Bacterial minicells to the rescue: cyto‐Immunotherapy for the treatment of late stage cancers with minimal to no toxicity
per: Himanshu Brahmbhatt, et al.
Publicat: (2022-01-01)

Reconstitution of antigen presentation in HLA class I-negative cancer cells with peptide-beta2m fusion molecules.
per: Tafuro, S, et al.
Publicat: (2001)

Specific surface area of titanium dioxide (TiO2) particles influences cyto- and photo-toxicity
per: Xiong, Sijing, et al.
Publicat: (2013)

Effect of mutations and variations of HLA-A2 on recognition of a virus peptide epitope by cytotoxic T lymphocytes.
per: Mcmichael, A, et al.
Publicat: (1988)

In Vitro and In Vivo Inhibitory Activities of Selected Traditional Medicinal Plants against Toxin-Induced Cyto- and Entero- Toxicities in Cholera
per: Rajitha Charla, et al.
Publicat: (2022-09-01)

Detailed and atypical HLA‐E peptide binding motifs revealed by a novel peptide exchange binding assay
per: Walters, LC, et al.
Publicat: (2020)

Discovery of HLA-E-presented epitopes: MHC-E/Peptide binding and t-cell recognition
per: Ruibal, P, et al.
Publicat: (2022)

HLA-E-presented peptides as novel targets for HIV-1 therapy
per: S. Brackenridge, et al.
Publicat: (2019-12-01)

Numerical study of the effects of hydrodynamic interactions among cells for microfluidic holographic cyto-tomography
per: Angela Vitolo, et al.
Publicat: (2024-03-01)

Importance of a conserved TCR J alpha-encoded tyrosine for T cell recognition of an HLA B27/peptide complex.
per: Bowness, P, et al.
Publicat: (1998)

Analysis of mutant HLA-A2 molecules. Differential effects on peptide binding and CTL recognition.
per: Tussey, L, et al.
Publicat: (1994)

Regulation of NK cell functions through interaction of the CD94/NKG2 receptors with the nonclassical class I molecule HLA-E.
per: Braud, V, et al.
Publicat: (1999)

Identification of a novel HLA-A2 subtype, HLA-A*0216.
per: Barouch, D, et al.
Publicat: (1995)

Identification of a novel HLA-B*3501-restricted cytotoxic T lymphocyte epitope using overlapping peptides.
per: Goulder, P, et al.
Publicat: (1997)